Edward W. Boyer

Edward W. Boyer's research addresses medical toxicology and addiction medicine, with particular attention to emerging drugs of abuse such as kratom-derived compounds (mitragynine, 7-hydroxymitragynine) and opioid use disorder. He also develops and tests digital health tools, including ingestible sensors and smartphone-based systems, to monitor medication adherence in populations such as HIV pre-exposure prophylaxis users and people with substance use disorders. This work spans clinical toxicology, addiction treatment, and mobile/digital health technology.

Publication output has remained fairly steady over the past decade, averaging around 3-5 papers per year, with a modest increase in the most recent two years (2024-2025).

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026